Capsida Biotherapeutics Poised to Capitalize on Industry-leading Gene Therapy Technology With New CEO, CSO, and CTO

THOUSAND OAKS, Calif.: THOUSAND OAKS, Calif., Dec. 7, 2021 /PRNewswire/ -- Capsida Biotherapeutics Inc., an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening genetic disorders, today announced the appointment of Peter Anastasiou as the company's Chief Executive Officer...

Click to view original post